At Labassure, we recognize the importance of proactive care during pregnancy—especially when it comes to high-risk conditions like pre-eclampsia. This potentially life-threatening hypertensive disorder can lead to serious complications for both mother and baby if not identified and managed in time. Our Pre-eclampsia Risk Assessment combines advanced biomarker testing to support early detection and informed clinical decision-making.

By measuring angiogenic and anti-angiogenic markers, this assessment helps predict the onset and progression of pre-eclampsia, particularly in women showing early signs such as elevated blood pressure or abnormal ultrasound findings.

In addition to standard assessments, Labassure offers specialized services such as

Key Benefits:
  • Women with elevated blood pressure or suspected pre-eclampsia
  • Pregnancies with abnormal placental findings on ultrasound
  • Women with a history of pre-eclampsia or other high-risk factors
  • Cases requiring differentiation between gestational hypertension and pre-eclampsia
Recommended For:
  • Early Risk Identification: Detects pre-eclampsia risk before clinical symptoms become severe.
  • Non-Invasive & Safe: Requires only a maternal blood sample.
  • Supports Clinical Management: Aids in triaging patients, planning delivery, and avoiding unnecessary hospitalizations.
  • Proven Predictive Value: Validated by international studies and incorporated into guidelines for high-risk pregnancy care.
  • Timely Intervention: Enables better monitoring and outcomes through proactive maternal-fetal medicine strategies.

Labassure’s Pre-eclampsia Risk Assessment offers clinicians a powerful tool for early intervention—helping ensure safer pregnancies and healthier outcomes for both mother and baby.

Placental Growth Factor
sFlt-1/PlGF Ratio